Cipla

Cipla Limited is an Indian multinational pharmaceutical company, headquartered in Mumbai, India. Cipla primarily develops medicines to treat respiratory, cardiovascular disease, arthritis, diabetes, weight control and depression; other medical conditions.

P/E

Net profit

P/B

Book value

P/FCF

FCF

Yield

Growth potential

Report period	2017	2018	2019	2020	2021	2022
End date of the reporting period
Capitalization, ₹
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Report period	2017	2018	2019	2020	2021	2022
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Report period	2017	2018	2019	2020	2021	2022
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Report period	2017	2018	2019	2020	2021	2022
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin

Ticker	Name	Type	Nominal value	ISIN	Price
CIPLA:IN	Cipla	Common share	-	INE059A01026	₹1,355

Cipla news

04.10.2021

Cipla has signed an agreement with Eli Lilly to sell and distribute two diabetes drugs, Trulicity and Humalog, in India. India has the second highest number of diabetes patients in the world, with more than 70 million adults with the disease.

Source:

reuters.com

All Cipla news

General information

Company name	Cipla
Sector	Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals
Business address	India, Mumbai, Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel
Mailing address	400013, India, Mumbai, Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel
Website	www.cipla.com

Cipla

Cipla balance sheet

Cipla cash flows

Cipla multipliers

Cipla profitability

Cipla dividend policy

Cipla shares